Effect of atorvastatin on renal fibrosis, oxidative stress and related factors in patients with diabetic nephropathy

Effect of atorvastatin on renal fibrosis, oxidative stress and related factors in patients with diabetic nephropathy

Objective: To investigate the effects of atorvastatin on renal function, renal fibrosis, oxidative stress and inflammatory factors in patients with diabetic nephropathy. Methods: A total of 120 patients with diabetic nephropathy admitted to People’s Hospital of De Yang, Sichuan, China were random...

Full description

Bibliographic Details
Main Authors:	Xiu Hu, Hai-Yan Li, Bin Song, Zu-Chun Liao, Wei Qing
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2019-05-01
Series:	Journal of Hainan Medical University
Subjects:	atorvastatin diabetic nephropathy renal function renal fibrosis oxidative stress inflammatory factors
Online Access:	http://www.hnykdxxb.com/PDF/201909/06.pdf

Similar Items

Effect of sodium ferulate in combined with atorvastatin on the renal interstitial fibrosis and inflammatory cytokines in patients with diabetic nephropathy
by: Li-Ming Wang, et al.
Published: (2018-08-01)

The Effect of Atorvastatin on Oxidative Stress and Renal Function in Experimental Model of Diabetic Nephropathy
by: Nastaran Faghihi, et al.
Published: (2016-01-01)

Effects of Compound α-Ketoacid Tablets on renal function, renal fibrosis indexes and oxidative stress in patients with diabetic nephropathy
by: Hai-Yun Dong, et al.
Published: (2018-09-01)

Psoralea corylifolia L. Seed Extract Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis and Apoptosis in Streptozotocin-Induced Diabetic Mice
by: Eunhui Seo, et al.
Published: (2017-08-01)

Research about the influence of alprostadil for the renal blood flow parameters and fibrosis indexes of patients with diabetic nephropathy
by: Li Ling, et al.
Published: (2016-01-01)

Effects of different doses of atorvastatin on NF-κB, inflammatory factors and insulin resistance in elderly patients with early diabetic nephropathy
by: Ying Liu, et al.
Published: (2016-01-01)

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
by: Shan Shan Qi, et al.
Published: (2020-03-01)

Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin
by: Xiao-peng Zheng, et al.
Published: (2020-05-01)

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
by: Peyman Bidram, et al.
Published: (2015-01-01)

Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy
by: M. P. Graham-Brown, et al.
Published: (2019-07-01)

Pterostilbene, a bioactive component of blueberries, alleviates renal fibrosis in a severe mouse model of hyperuricemic nephropathy
by: Jing Pan, et al.
Published: (2019-01-01)

Impact of high dose versus low dose atorvastatin on contrast induced nephropathy in diabetic patients with acute coronary syndrome undergoing early percutaneous coronary intervention
by: Haitham Galal, et al.
Published: (2015-12-01)

Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
by: Eugene Han, et al.
Published: (2017-06-01)

ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
by: Yu-Li Shen, et al.
Published: (2020-01-01)

Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy
by: Liu K, et al.
Published: (2019-08-01)

Protective role of relaxin in a mouse model of aristolochic acid nephropathy
by: Xiu Yang, et al.
Published: (2019-07-01)

Anti-Inflammatory Effects of Atorvastatin by the Modulation of NF-κB Expression during Hyperglycemia-Induced Nephropathy in Rat
by: Mohammad Taghi Mohammadi, et al.
Published: (2016-03-01)

Molecular mechanisms for Haikunshenxi capsule combined with conventional western medicine to improve renal function in patients with diabetic nephropathy
by: Jian-Guo Zhang
Published: (2017-06-01)

The Preventive Effect of Atorvastatin on Paraquat-Induced Pulmonary Fibrosis in the Rats
by: Mohammad Javad Khodayar, et al.
Published: (2014-12-01)

Influence of astragalus polysaccharide on kidney status and fibrosis indices of a rat model of streptozotocin-induced diabetic nephropathy
by: Yue Ji, et al.
Published: (2018-07-01)

Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy
by: Chen Xuan, et al.
Published: (2021-04-01)

Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy
by: Miho Shimizu, et al.
Published: (2021-09-01)

Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy
by: Miho Shimizu, et al.
Published: (2019-07-01)

Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis
by: E Xiang, et al.
Published: (2020-08-01)

Renal histology in diabetic nephropathy: "A novel perspective"
by: M Sahay, et al.
Published: (2014-01-01)

Correlation of serum Leptin and Vaspin contents with renal function, oxidative stress and inflammatory response in patients with diabetic nephropathy
by: Yun Ruan, et al.
Published: (2018-09-01)

Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy
by: Junlin Zhang, et al.
Published: (2018-10-01)

Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy
by: Gyl Eanes Barros Silva, et al.
Published: (2012-07-01)

Serum Matrix Metalloproteinase-7 Level is Associated with Fibrosis and Renal Survival in Patients with IgA Nephropathy
by: Jian Zhang, et al.
Published: (2017-09-01)

Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
by: Yiyun Wang, et al.
Published: (2020-03-01)

Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy
by: Sheila Bermejo, et al.
Published: (2016-09-01)

Usefulness of real-time sonoelastography for assessment of renal allograft fibrosis
by: Ram Dayal Sahu, et al.
Published: (2020-01-01)

Renal allograft nephropathy in patient with type 1 diabetes mellitus
by: Ekaterina Vladimirovna Ivannikova, et al.
Published: (2012-03-01)

Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice
by: Yang GN, et al.
Published: (2017-03-01)

URINARY EXCRETION OF PROFIBROTIC AND ANTIFIBROTIC GROWTH FACTORS IN TYPE 1 DIABETIC PATIENTS: THE RELATION WITH DIABETIC NEPHROPATHY
by: I A Bondar, et al.
Published: (2012-06-01)

Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression
by: Xuyu He, et al.
Published: (2016-05-01)

Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
by: Priscila Calle, et al.
Published: (2020-04-01)

Effect of paecilomyces hepiall chen on serum inflammatory factors, oxidative stress and renal function in patients with diabetic nephropathy
by: Wen Zhang, et al.
Published: (2017-10-01)

Evaluation of renal function and oxidative stress after adjuvant epalrestat treatment of early diabetic nephropathy
by: Ge Zhao, et al.
Published: (2017-04-01)

Calreticulin is important for the development of renal fibrosis and dysfunction in diabetic nephropathy
by: Ailing Lu, et al.
Published: (2020-11-01)